1.浙江中医药大学附属第三医院,浙江省杭州市莫干山路219号,310005
2.浙江中医药大学公共卫生学院
通信作者:jchi2005@126.com
收稿:2025-09-10,
修回:2025-12-10,
纸质出版:2026-02-17
移动端阅览
王纪兴,周芷伊,林思思等.基于循证医学的中医药适宜技术评价体系构建策略[J].中医杂志,2026,67(04):355-359.
WANG Jixing,ZHOU Zhiyi,LIN Sisi,et al.Construction of an Evaluation System for Traditional Chinese Medicine Appropriate Technologies Based on Evidence-Based Medicine[J].Journal of Traditional Chinese Medicine,2026,67(04):355-359.
王纪兴,周芷伊,林思思等.基于循证医学的中医药适宜技术评价体系构建策略[J].中医杂志,2026,67(04):355-359. DOI: 10.13288/j.11-2166/r.2026.04.002.
WANG Jixing,ZHOU Zhiyi,LIN Sisi,et al.Construction of an Evaluation System for Traditional Chinese Medicine Appropriate Technologies Based on Evidence-Based Medicine[J].Journal of Traditional Chinese Medicine,2026,67(04):355-359. DOI: 10.13288/j.11-2166/r.2026.04.002.
基于循证医学理论构建中医药适宜技术的多维度评价体系框架,涵盖证据、实施者、患者三个核心维度。针对当前中医药适宜技术推广中面临的高质量证据缺乏、操作规范不一、患者接受度差异等现实问题,提出整合文献证据与真实世界研究数据,建立科学性、适用性并重的评价路径。在证据维度,强调应从有效性、安全性和经济性等方面进行系统评估,并引入模拟目标试验等方法提升证据质量;在实施者维度,提出从教育背景、培训考核与临床疗效等多层面建立能力评价工具;在患者维度,则需综合考虑技术特性、疗效预期、医患互动及替代方案等因素设计患者接受度测评工具,以期为中医药适宜技术的规范化推广和精准化应用提供方法论支持。
Based on the theory of evidence-based medicine (EBM), this paper systematically constructed a multi-dimensional evaluation framework for traditional Chinese medicine (TCM) appropriate technologies, encompassing three core dimensions including evidence, practitioner, and patient. For the current practical challenges in the promotion of TCM technologies such as lack of high-quality evidence, inconsistent operational standards, and varying patient acceptance, the paper proposed the integration of published literature evidence and real-world research data to construct a scientific and applicable evaluation pathway. Regarding the evidence dimension, it emphasizes syste-matic assessment of effectiveness, safety, and economic efficiency, introducing methods like the target trial emulation framework to enhance evidence quality; for the practitioner dimension, it suggests developing multi-aspects competency evaluation tools based on educational background, training assessment, and clinical outcomes; for the patient dimension, it recommends designing patient acceptance assessment tools by considering factors such as technical characte-ristics, expected efficacy, patient-practitioner interaction, and the availability of alternative treatments. The purpose of the above measures is to provide methodological support for the standardized popularization and precision application of TCM appropriate technologies.
Evidence-Based Medicine Working Group . Evidence-based medicine. A new approach to teaching the practice of medicine [J]. JAMA , 1992 , 268 ( 17 ): 2420 - 2425 .
MONTORI VM , GUYATT GH . Progress in evidence-based medicine [J]. JAMA , 2008 , 300 ( 15 ): 1814 - 1816 .
王丹 , 车文文 , 邱继文 , 等 . 基于层次分析法建立中医适宜技术筛选评价体系 [J]. 中医杂志 , 2019 , 60 ( 17 ): 1468 - 1472 .
国务院办公厅 . 国务院办公厅印发中医药振兴发展重大工程实施方案 [EB/OL].( 2023-02-28 ) [ 2025-05-11 ]. https://www.gov.cn/xinwen/2023-02/28/content_5743722.htm https://www.gov.cn/xinwen/2023-02/28/content_5743722.htm .
顾仁君 , 熊季霞 , 陈浩 , 等 . 中医针刺适宜技术评价指标体系构建与应用 [J]. 中国社会医学杂志 , 2022 , 39 ( 3 ): 348 - 351 .
AI DD , SUI BY , DUAN CA , et al . Health technology assessment in traditional and complementary medicine: a scoping review of international activity and examples of acupuncture [J]. Int J Technol Assess Health Care , 2024 , 40 ( 1 ): e24 .
季聪华 , 郭清 . 基于循证医学的中医优势病种评价标准思考 [J]. 中华中医药杂志 , 2022 , 37 ( 1 ): 277 - 280 .
中华中医药学会《中医药真实世界研究技术规范》制订组 . 中医药真实世界研究技术规范:证据质量评价与报告 [J]. 中医杂志 , 2022 , 63 ( 3 ): 293 - 300 .
SUBBIAH V . The next generation of evidence-based medicine [J]. Nat Med , 2023 , 29 ( 1 ): 49 - 58 .
冀来喜 . 针灸适宜病种优势技术组合治疗 [M]. 北京 : 人民卫生出版社 , 2018 .
HE Y , GUO X , MAY BH , et al . Clinical evidence for association of acupuncture and acupressure with improved cancer pain: a systematic review and meta-analysis [J]. JAMA Oncol , 2020 , 6 ( 2 ): 271 - 278 .
QIN C , MA H , NI H , et al . Efficacy and safety of acupuncture for pain relief: a systematic review and meta-analysis [J]. Support Care Cancer , 2024 , 32 ( 12 ): 780 .
COLLINS R , BOWMAN L , LANDRAY M , et al . The magic of randomization versus the myth of real-world evidence [J]. N Engl J Med , 2020 , 382 ( 7 ): 674 - 678 .
林奕 , 王学谦 , 赵晖 , 等 . 中医优势病种评价的方法学探讨 [J]. 中医杂志 , 2021 , 62 ( 19 ): 1663 - 1667 .
BALSHEM H , HELFAND M , SCHUNEMANN HJ , et al . GRADE guidelines:3. Rating the quality of evidence [J]. J Clin Epidemiol , 2011 , 64 ( 4 ): 401 - 406 .
王禹毅 , 马文欣 , 王雪惠 , 等 . 模拟目标试验及其在中医药研究中应用的可行性分析 [J]. 中医杂志 , 2023 , 64 ( 19 ): 1969 - 1974 .
KOTECHA D , ASSELBERGS FW , ACHENBACH S , et al . CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research [J]. BMJ , 2022 , 378 : e069048 . doi: 10.1136/bmj-2021-069048 http://dx.doi.org/10.1136/bmj-2021-069048 .
陈薇 , 陈可冀 , 刘建平 . 中医药真实世界研究证据的构成及分级标准建议 [J]. 中国中西医结合杂志 , 2021 , 41 ( 5 ): 608 - 611 .
潘波 , 王未寒 . 以岗位胜任力为导向的中医规培医师中医药适宜技术教学实践研究 [J]. 浙江中医药大学学报 , 2024 , 48 ( 10 ): 1311 - 1314 .
韩梅 , 曹卉娟 , 张颖 , 等 . 单组试验目标值法及其在中医非药物疗法评价中的应用 [J]. 北京中医药 , 2020 , 39 ( 5 ): 499 - 503 .
王瀚东 , 柴倩云 , 冯玉婷 , 等 . 中医药临床疗效评价中目标值法单臂试验适用性与理论对策的定性研究 [J]. 中国循证医学杂志 , 2024 , 24 ( 11 ): 1317 - 1324 .
LIANG Z , XU M , LIU G , et al . Patient-centred care and patient autonomy: doctors' views in Chinese hospitals [J]. BMC Medical Ethics , 2022 , 23 ( 1 ): 38 .
KARAM SG , ZHANG Y , PARDO-HERNANDEZ H , et al . ROBVALU: a tool for assessing risk of bias in studies about people's values, utilities, or importance of health outcomes [J]. BMJ , 2024 , 385 : e079890 . doi: 10.1136/bmj-2024-079890 http://dx.doi.org/10.1136/bmj-2024-079890 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号